Recent Headlines
Creative Biomart Launches Special Promotion for Christmas and New Year
Creative Biomart, a world leading biotech company that provides recombinant proteins, enzymes and other quality products and services for customers all over the world, has announced today that they would launch a special promotion for Christmas and New year in this very day. According to its... - December 25, 2014 - Creative Biomart
The American Academy of Anti-Aging Medicine (A4M) concluded their largest event December 14, 2014 in Las Vegas, NV
Thousands of medical practitioners gathered at the Venetian/Palazzo Resort in Las Vegas, NV for the 22nd Annual World Congress on Anti-Aging Medicine. This three-day event proved to be the largest the A4M has ever hosted, as it represented the most attendees, faculty speakers and exhibiting... - December 25, 2014 - A4M
Creative Biomart Newly Introduced Multiplex Protein Detect Assay
Creative Biomart, a world leading biotech company and the commitment of which is to improving people’s life by assisting scientists with their research, has announced today for its official release of Multiplex Protein Detect Assay Service. This release was said to provide better protein... - December 21, 2014 - Creative Biomart
Experimentica Ltd. Licenses Akimba Mouse Model for Diabetic Retinopathy from Lions Eye Institute, Australia
The Lions Eye Institute (LEI) and Experimentica Ltd., a global ophthalmic contract research organization (CRO) announced today that they have entered into an exclusive license agreement for the Akimba mouse model for diabetic retinopathy for contract research. The license agreement was facilitated by Bio-Link Australia, a life sciences commercialisation company. - December 20, 2014 - Experimentica Ltd
Downloadable Healthcare Metrics: 2014 Rise in Embedded Case Management Driven by Accountable Care Savings
Two-thirds of healthcare organizations have amped up care coordination across the continuum by embedding or colocating case managers at points of care, according to the latest complimentary HINtelligence report from the Healthcare Intelligence Network. - December 19, 2014 - Healthcare Intelligence Network
Theravectys Launches Its New Website & Wins Deloitte’s Technology Fast50 "2014 Biotech d’Avenir" Award
A rewarding November for the promising French biotech: a prestigious prize & an impactful communication tool! Theravectys wins Deloitte Technology Fast 50 “2014 Biotech d’Avenir,” a prize awarded to one of the fastest-growing, most innovative & dynamic biotech company of the year. In addition, Theravectys is proud to announce the launch of its responsive and easy-to-navigate website www.theravectys.com featuring new sections & content. - December 18, 2014 - Theravectys
2015 Healthcare Forecast: Prepare for Post-Acute Care Activity, Payor Disintermediation, Transparency Pressure
Healthcare stakeholders should brace for new market entrants, more data and price transparency and an increasingly global playing field, according to HIN's eleventh annual industry trends report. - December 15, 2014 - Healthcare Intelligence Network
Clinical and Economic Impact of Next-Generation Sequencing Examined During Boston Healthcare’s Multi-Stakeholder Symposium
Boston Healthcare Associates, Inc. (BHA) and Cambridge Healthtech Institute (CHI) held an engaging, multi-stakeholder symposium surrounding the unique challenges and opportunities with the use of next-generation sequencing (NGS) in oncology care. Entitled, “Capturing the Value of... - December 12, 2014 - Boston Healthcare
Paras Biopharmaceuticals Wins International Award
Paras Biopharmaceuticals wins the 2014 European Biopharmaceuticals Technology Innovation Leadership Award by Frost & Sullivan. - December 11, 2014 - Paras Biopharmaceuticals Finland Oy
EGFR Kit of AmoyDx, China, Supplier to MoBiTec, Germany, Ranks Top in 2014 Lung Cancer EMQN Report
The European Molecular Genetics Quality Network (EMQN) is an independent organization based in the UK that promotes improvement in the quality of genetic testing by ensuring that diagnostic molecular genetic laboratory test results are accurate, reliable, and comparable. - December 11, 2014 - MoBiTec GmbH
ALPCO Releases New Chemiluminescent Human C-peptide ELISA
ALPCO adds to their STELLUX® Chemiluminescent line of assays with the launch of the new Human C-peptide ELISA. - December 10, 2014 - ALPCO
AveXis Announces Dosing of First Patient in Intermediate Cohort in Gene Transfer Trial
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced that the first patient in the intermediate cohort in the Gene Transfer Clinical Trial for SMA Type 1 has... - December 10, 2014 - AveXis Inc.
New Report: Medicare Chronic Care Management Revenue Opportunities for Physician Practices
A new report details 2015 revenue opportunities for physician practices who coordinate care for Medicare beneficiaries with chronic illness, based on the 2015 Medicare Physician Fee Schedule. - December 09, 2014 - Healthcare Intelligence Network
Ryte Launches as First Benefit Corporation in Direct Sales Industry
Ryte is honored to launch as the first Benefit Corporation in the Direct Sales industry. Ryte is a giving company, and offers its Members the opportunity to live an active, healthy lifestyle and at the same time give back to causes, people, and programs they are passionate about. Ryte’s product lineup is designed to help in areas where most people struggle, including energy, weight loss, mood, relaxation, and sleep (www.ryte.com). - December 09, 2014 - Ryte, Inc
Get the First Mover Advantage in “The Big Value” Gene Therapy Market
Take Advantage of the very lucrative gene therapy market and play in the rare-air of the very few with DelveInsight’s Gene Therapy Reports! - December 07, 2014 - DelveInsight
Kelyniam Global Announces Q2 and Q3 Earnings
Kelyniam Global, Inc. (OTC Pink: KLYG), an innovative medical device design and manufacturing company, posted its 2nd & 3rd quarter sales at $436,865 and $455,401 respectively. The reduction in quarterly revenue can be directly attributed to company resources allocated to its recent acquisition... - December 06, 2014 - Kelyniam Global, LLC
AveXis Announces Launch of New Patient-Oriented Website Focused on Spinal Muscular Atrophy
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), is pleased to announce the launch of the company’s brand new website specifically focused on SMA: www.smastudy.org. - December 04, 2014 - AveXis Inc.
Essjay Solutions Presenting at 4th Annual Pharmacovigilance Conference in Dubai
Essjay Solutions are pleased to announce they will be presenting at the 4th Annual Pharmacovigilance Conference organised by MCO on 15th January 2015 in Dubai. This conference aims to improve awareness of pharmacovigilance from a theoretical and practical point of view, as well as introduce successful models and experience in pharmacovigilance in the Middle East. - December 04, 2014 - Essjay Solutions
Discount on DelveInsight’s Market & Pipeline Reports Till 26th December, 2014
Meet your Targets with DelveInsight's Comprehensive Reports which are now available at a lesser price. - December 03, 2014 - DelveInsight
MoBiTec, Germany to Offer Cryogenic Vials for Embryo Cryopreservation by Vitrification Manufactured by Sumitomo, Japan
In cryopreservation vitrification is a common method used to preserve egg cells and embryos. Of utmost importance is that the oocyte or embryo is stored in a vessel that allows appropriate temperature modulation. - December 03, 2014 - MoBiTec GmbH
Publisher Seeks Feedback for 10th Annual "State of the Healthcare Industry" Survey
The Healthcare Intelligence Network extends its yearly invitation to industry executives to identify 2014 business triumphs as well as top-of-mind 2015 concerns and challenges by completing the publisher's tenth annual Trends & Forecasts survey. - December 01, 2014 - Healthcare Intelligence Network
Just in Time for Cyber Monday SkinnyTeaUSA™ Announces the Launch of Its New Holiday Shop and Store-Wide Discounts on New Limited Edition Holiday Blends
SkinnyTeaUSA™ the leading US-based weight management tea company, is now operating a new independent Holiday online store (shop.skinnytea.us) in anticipation of the Holiday shopping rush that previously overwhelmed the main SkinnyTeaUSA™ website. The Holiday store only carries exclusive Limited Edition Holiday tea blends. - November 30, 2014 - SkinnyTeaUSA
MoBiTec, Germany, Offers a New Range of Monofluorinated Nucleosides Manufactured by Dextra, UK
Fluorine introduction can lead to a modification of the reactivity of functional groups, alter conformational stability and, in pharmaceuticals, enhance metabolic stability. Over 30% of leading blockbuster drugs contain at least one fluorine atom. - November 29, 2014 - MoBiTec GmbH
The “New” Way Forward: DelveInsight’s Oncology-Based MOA Pipeline Reports
Move one Step ahead from the Market with These Target-Based Reports. - November 28, 2014 - DelveInsight
electroCore CEO, JP Errico, Emphasizes the Importance of Early Collaboration with Patients Group, Providers, and Payors When Introducing Innovative Technologies
JP Errico, founder and CEO of electroCore, speaking at The FT Global Pharmaceutical and Biotechnology Conference in London last week, emphasized the importance of working with each of the major stakeholders, i.e., patients and their advocates, key opinion-leading physicians, and decision-makers... - November 28, 2014 - electroCore
Creative Biomart’s Most-Favored Services List is Available Now
Creative Biomart, a world leading biotech company that offers recombinant proteins, antibodies, antigens and a wide range of biotech services worldwide, today has released its most favored services list officially. It was said that this was done to make them have a better understanding of what... - November 22, 2014 - Creative Biomart
AveXis to Present at the 26th Annual Piper Jaffray Healthcare Conference
AveXis, a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy, today announced that Mr. John Carbona, Chief Executive Officer, and Dr. Brian Kaspar will present at the 26th Annual Piper Jaffray... - November 21, 2014 - AveXis Inc.
Patent Awarded to AdvantaPure(R)’s AdvantaPass(TM) Clean Room Wall Pass-Through System; Ensures Room Isolation During Fluid Transfer
A United States patent has been awarded to AdvantaPass, a clean room wall pass-through system designed to transfer fluids between clean rooms during pharmaceutical and biopharmaceutical production. The system is the first of its kind to provide complete isolation between manufacturing suites when transferring multiple fluid lines through a single wall portal. AdvantaPass uses Single-Use components, such as tubing and seals, along with durable stainless steel in-wall parts. - November 20, 2014 - AdvantaPure
Available from MoBiTec GmbH: Unique Ready-to-Use Vectors for Live Cell Imaging of Nuclear Proteins
During cell division the kinetochore is the protein structure on chromatids where the spindle fibers attach to pull sister chromatids apart. MoBiTec now offers unique gene fusion constructs of proteins to investigate kinetochore formation and cell division. - November 20, 2014 - MoBiTec GmbH
December 16, 2014 Webinar: Humana to Detail Physician Quality Rewards for Population Health Management
Drawing upon its rich five-year experience of supporting physician practices' transition from volume to value, Humana will describe its value-based Provider Quality Rewards program during a December 16, 2014 webinar sponsored by the Healthcare Intelligence Network. - November 19, 2014 - Healthcare Intelligence Network
Experimentica Ltd Announces a Strategic Partnership with the Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland
Experimentica Ltd., a Finland-based ophthalmic CRO, announces a strategic partnership with The Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland. SILK is a research network composed of research units engaged in basic and clinical eye and vision research. Dr. Giedrius... - November 19, 2014 - Experimentica Ltd
Brachytherapy Market Driven by New Technologies and New Indications
The global market for brachytherapy reached US$ 680 million in 2013, and the trend is toward a growth driven by new technologies (electronic brachytherapy, microspheres), new indications for LDR (lung, liver) and new markets (Asia, South America). - November 14, 2014 - MEDraysintell
MoBiTec GmbH, Germany, Offers New Bacillus Megaterium Strain for Gene Expression and Protein Production - YYBm1
MoBiTec GmbH expands its product line of tools for gene expression in Bacillus megaterium with the new expression host YYBm1. Strain YYBm1 is unable to utilize the expression system's inductor molecule xylose as carbon source. - November 13, 2014 - MoBiTec GmbH
MoBiTec GmbH's Supplier Peninsula Laboratories, USA, with New Corporate Website
Peninsula Laboratories International, Inc, USA, a leading supplier of superior immunology products, proudly announces its own corporate website www.penlabs.com. Formerly, PenLabs was integral part of Bachem's internet presence. - November 11, 2014 - MoBiTec GmbH
Stratifying High-Risk Patients in Value-Based Healthcare: Procurement, Integrity of Clinical Data Challenge Segmentation
While the tactic of stratifying high-risk high-cost individuals for targeted care management is championed in a value-based industry, the procurement of clinical data and verifying data integrity are the top challenges of segmenting patients by health risk, according to a new HINtelligence report. One-third of organizations stratifying patients by health risk report reductions in hospital readmissions. - November 10, 2014 - Healthcare Intelligence Network
Value-Based Reimbursement Answer Book Provides Framework for Healthcare's New Value Proposition
Early champions of value-based healthcare payments educate the C-suite on the practicalities of accountable care organizations, shared savings, bundled payments and other value-focused initiatives in this new resource from the Healthcare Intelligence Network. - November 10, 2014 - Healthcare Intelligence Network
DelveInsight Launched 500 API Reports: Pharm API
DelveInsight has launched 500 API Insights Reports in the market based on drugs and Indications. - November 08, 2014 - DelveInsight
Metrics Scientist Presents Case Study at AAPS on Merits of Trying and Testing
Dr. Anshul Gupte, associate director of pharmaceutical development, has evaluated the correlation between the type of binder used in the formulation on the roller compaction processing parameters and subsequent tablet properties. - November 08, 2014 - Metrics, Inc.
Enzyme Activity Assay Service Are Available in Creative Biomart
Creative Biomart, a world leading supplier of recombinant proteins, antibodies, enzymes and other biotech services for the research community in the field of biology, has announced today for its official release of the novel service-- Enzyme activity assay. This assay is in the aim of assisting... - November 06, 2014 - Creative Biomart
VMRD’s Q Fever FA Substrate Slide Now Available
VMRD announced today the availability of a substrate slide that can be used for the detection of antibody to Coxiella burnetii (Q fever). The slide can detect antibody to phases I & II of Q fever. - November 05, 2014 - VMRD, Inc.
How One Start-Up is Single Handedly Changing the Face of Cannabis Tourism
The Travel Joint which launched in December 2012, is a luxury branded marijuana site dealing in travel, media and lifestyle. They offer full-service, a-la-carte travel and ticketing services. You can book a flight, (commercial or private), find a hotel, buy event or sport tickets and make restaurant reservations all while their private concierge service takes care of transportation and dispensary visitations. Without ever leaving the United States. - November 04, 2014 - The Travel Joint
ABR Launches New Mycoplasma Testing Services
ABR (now a VMRD division) announced today the availability of new testing services that can detect the presence of mycoplasma in animal origin products, master virus seeds, and other sample types. The new services satisfy various regulatory standards including US Pharmacopoeia (USP), European... - November 04, 2014 - VMRD, Inc.
Realm Labs Releases NeuRemedy Plus
Realm labs announces the launch of NeuRemedy Plus™ as an addition to its popular NeuRemedy® product line. - October 30, 2014 - Realm Labs LLC
Metrics Contract Services Scientist Awarded Patent for Zero-Order Release Tablet Technology
Dr. Brad Gold, vice president of pharmaceutical development, has received a U.S. patent for his intellectual property about controlled release technology. - October 30, 2014 - Metrics, Inc.
November 19 Webinar: New Revenue Opportunities from Medicare Chronic Care Management Reimbursement
The law firm of McDonald Hopkins will examine patient and physician practice eligibility, IT infrastructure and billing requirements for 2015 Medicare chronic care management during a November 19, 2014 webinar sponsored by the Healthcare Intelligence Network (HIN). - October 28, 2014 - Healthcare Intelligence Network
Xtend-Life Natural Products Expands Into Chinese Marketplace
Natural supplements, skin care products from www.xtend-life.com now available via Tmall Global. - October 27, 2014 - Xtend-Life Natural Products
11th Annual Healthcare Trends Webinar Offers Roadmap for 2015 Strategic Planning
A November 13, 2014 strategic planning session will provide a roadmap to key issues, challenges and opportunities for providers and payors in 2015, including value-based reimbursement, population health management, telehealth, narrow networks, and more. - October 27, 2014 - Healthcare Intelligence Network
The American Academy of Anti-Aging Medicine (A4M) Announces Specialty Conference Workshops Taking Place at the 22nd Annual World Congress on Anti-Aging Medicine
The American Academy of Anti-Aging Medicine (A4M) Announces Specialty Conference Workshops taking place in conjunction with the 22nd Annual World Congress on Anti-Aging Medicine in Las Vegas. The A4M will host its largest continuing medical education conference December 11-13, 2014, bringing... - October 25, 2014 - A4M
Trial Reported in Headache and Pain Journal Further Confirms the Effectiveness of electroCore’s Non-Invasive Vagus Nerve Stimulation Treatment for Headache
Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore’s hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes, with an additional 11.4%... - October 25, 2014 - electroCore
Amoy Diagnostics, China, Expands List of CE-Marked Real-Time PCR Kits for Cancer Diagnostics
Amoy Diagnostics, who recently appointed MoBiTec GmbH as distributor for Germany, proudly announces the availability of further CE-marked detection kits, which are based on a proprietary real-time PCR technology called “ADx-ARMS,” for Cancer Diagnostics. - October 24, 2014 - MoBiTec GmbH